Targeting RCAN1 to treat type 2 diabetes and obesity [ 2018 - 2020 ]

Research Grant

Researchers: Prof Damien Keating (Principal investigator)

Brief description Obesity and impaired insulin secretion are significant contributors to Type 2 diabetes. In this project we demonstrate that a protein called RCAN1 contributes to both fat mass and insulin secretion and that this contribution is exacerbated in obesity and in Type 2 diabetes. We will identify how RCAN1 controls these major metabolic pathways with outcomes including the development of new therapeutics for obesity and Type 2 diabetes.

Funding Amount $AUD 825,870.75

Funding Scheme Project Grants

Notes Standard Project Grant